On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
Arsenic is generally considered hypertoxic. However, it has been used in traditional Chinese medicine since ancient times, to treat serious illnesses. Recently, a single dose of arsenic trioxide (As2O3) has been found especially effective in treating acute promyelocytic leukemia (APL). Generally spe...
Main Author: | Peng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | Leukemia Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048917300080 |
Similar Items
-
Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
by: Akiko Hashimoto, et al.
Published: (2021-07-01) -
Unusual massive bone marrow fibrosis in acute promyelocytic leukemia following arsenic trioxide therapy
by: S. Venkatesan, et al.
Published: (2015-01-01) -
Acute promyelocytic leukemia. State of the art
by: Leonardo Mejía-Buriticá, et al.
Published: (2021-01-01) -
Experimental study on the inhibitory effect of arsenic trioxide combined with phorbol ester on the proliferation of acute promyelocytic leukemia cell line Kasumi-1
by: Na Zhang1, et al.
Published: (2017-05-01) -
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
by: McCulloch D, et al.
Published: (2017-03-01)